The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Chemotherapy associated myelosuppression and disease-free and overall survival: A systematic review and evidence summary.
Marek S. Poniewierski
No relevant relationships to disclose
Adane Wogu
No relevant relationships to disclose
Eva Culakova
No relevant relationships to disclose
Alexander Rosen
No relevant relationships to disclose
Nicole Maria Kuderer
Research Funding - Amgen (I)
Jeffrey Crawford
Consultant or Advisory Role - Amgen
David C. Dale
Consultant or Advisory Role - Amgen
Research Funding - Amgen
Gary H. Lyman
Research Funding - Amgen